Expression Profiles of GILZ and SGK-1 in Potentially Malignant and Malignant Human Oral Lesions.

GILZ SGK-1 benign keratosis epithelial dysplasia human immunohistochemistry leukoplakia squamous cell carcinoma

Journal

Frontiers in oral health
ISSN: 2673-4842
Titre abrégé: Front Oral Health
Pays: Switzerland
ID NLM: 9918227262706676

Informations de publication

Date de publication:
2021
Historique:
received: 02 03 2021
accepted: 13 08 2021
entrez: 20 1 2022
pubmed: 21 1 2022
medline: 21 1 2022
Statut: epublish

Résumé

Glucocorticoid-induced leucine zipper and serum-glucocorticoid-regulated kinase-1 (SGK-1) are major glucocorticoid-inducible proteins. Recent studies indicate the local production of cortisol in oral mucosa, which can impact the tissue generation of glucocorticoid-induced leucine zipper (GILZ) and SGK-1. Furthermore, GILZ and SGK-1 play pathogenic roles in a variety of cancers, but their status in potentially malignant (e.g., epithelial dysplasia) or malignant oral lesions remains unknown. This study tested the hypothesis that expression profiles of GILZ and SGK-1, along with the phosphorylated (active) form of SGK-1 (pSGK-1), are different in epithelial dysplasia than squamous cell carcinoma. Accordingly, archived paraffin-embedded biopsy samples were subjected to immunohistochemistry to establish tissue localization and the profile of proteins of interest, while hematoxylin-eosin stained tissues were used for histopathological assessment. Based on histopathological examinations, tissue specimens were categorized as displaying mild-moderate or severe epithelial dysplasia and squamous cell carcinoma; benign keratosis specimens served as controls. All the tissue specimens showed staining for SGK-1 and pSGK-1; however, while SGK-1 staining was primarily cytoplasmic, pSGK-1 was mainly confined to the cell membrane. On the other hand, all the tissue specimens displayed primarily nuclear staining for GILZ. A semi-quantitative analysis of immunohistochemistry staining indicates increased GILZ expression in epithelial dysplasia but reversal in squamous cell carcinoma to a level seen for benign keratosis. On the other hand, the SGK-1 and pSGK-1 expressions decreased for squamous cell carcinoma specimens compared with benign keratosis or dysplastic specimens. Collectively, in this cross-sectional study, immunostaining patterns for proteins of interest do not seemingly differentiate epithelial dysplasia from squamous cell carcinoma. However, subcellular localization and expression profiles for GILZ, SGK-1, and pSGK-1 are suggestive of differential functional roles in dysplastic or malignant oral lesions compared with benign keratosis.

Identifiants

pubmed: 35048019
doi: 10.3389/froh.2021.675288
pmc: PMC8757717
doi:

Types de publication

Journal Article

Langues

eng

Pagination

675288

Informations de copyright

Copyright © 2021 Mozaffari and Abdelsayed.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Oral Dis. 2021 Nov;27(8):1862-1880
pubmed: 33128420
Cell Physiol Biochem. 2017;43(3):1301-1308
pubmed: 28992614
Oncotarget. 2015 Mar 30;6(9):6931-43
pubmed: 25749387
J Chemother. 2020 Sep;32(5):263-267
pubmed: 32067575
Immunity. 1997 Dec;7(6):803-12
pubmed: 9430225
J Biol Chem. 2001 May 18;276(20):16649-54
pubmed: 11278764
Int J Biochem Cell Biol. 2017 Apr;85:166-174
pubmed: 28259749
Oral Oncol. 2017 Feb;65:23-32
pubmed: 28109464
Oral Dis. 2018 Mar;24(1-2):224-227
pubmed: 29480615
J Exp Clin Cancer Res. 2012 Jan 12;31:4
pubmed: 22240294
Biochem J. 2013 Jun 15;452(3):499-508
pubmed: 23581296
BMC Cancer. 2020 Feb 27;20(1):161
pubmed: 32106831
Mol Cell Biol. 1993 Apr;13(4):2031-40
pubmed: 8455596
Mol Cancer. 2009 Oct 08;8:83
pubmed: 19814803
Semin Cancer Biol. 2018 Oct;52(Pt 2):228-240
pubmed: 29355614
Growth Factors. 2010 Dec;28(6):394-408
pubmed: 20919962
Nat Rev Immunol. 2017 Apr;17(4):233-247
pubmed: 28192415
J Steroid Biochem Mol Biol. 2004 Aug;91(4-5):225-39
pubmed: 15336700
J Clin Invest. 2007 Jun;117(6):1605-15
pubmed: 17492054
J Clin Invest. 2015 Sep;125(9):3347-55
pubmed: 26325032
J Pharmacol Exp Ther. 2020 Dec;375(3):398-405
pubmed: 33008869
J Oral Maxillofac Surg. 2017 Sep;75(9):1980-1986
pubmed: 28189660
Br J Pharmacol. 2014 Feb;171(3):735-45
pubmed: 24172143
Am J Hypertens. 2014 Jun;27(6):846-56
pubmed: 24429675
Bio Protoc. 2019 Dec 20;9(24):
pubmed: 31867411
Oral Dis. 2018 Mar;24(1-2):179-183
pubmed: 29480606
Cell Death Dis. 2018 Apr 26;9(5):463
pubmed: 29695779
Oncogene. 2011 Jul 14;30(28):3198-206
pubmed: 21478911
Sci Rep. 2016 Jul 28;6:30405
pubmed: 27465291
PLoS One. 2014 Dec 08;9(12):e113795
pubmed: 25485633
Oral Dis. 2018 Mar;24(1-2):138-143
pubmed: 29480616
Cancer Lett. 2004 Jul 8;210(1):95-100
pubmed: 15172126
Cell Physiol Biochem. 2015;35(5):2006-18
pubmed: 25871776
Horm Cancer. 2014 Apr;5(2):72-89
pubmed: 24615402
Clin Dermatol. 2017 Sep - Oct;35(5):461-467
pubmed: 28916027
Exp Dermatol. 2014 Jun;23(6):369-374
pubmed: 24888781
Crit Rev Oncol Hematol. 2018 Jun;126:37-44
pubmed: 29759565
Int J Oncol. 2012 Nov;41(5):1751-61
pubmed: 22923130
Steroids. 2016 Jul;111:84-88
pubmed: 26930575
Breast Cancer Res Treat. 2012 Sep;135(2):469-79
pubmed: 22842983
J Cell Physiol. 2016 Nov;231(11):2368-73
pubmed: 27115293
J Cell Sci. 2019 Apr 9;132(7):
pubmed: 30837283
Cytokine Growth Factor Rev. 2010 Feb;21(1):11-9
pubmed: 20018552
J Pathol Transl Med. 2018 May;52(3):141-147
pubmed: 29621880
J Dent Res. 2012 Jan;91(1):97-103
pubmed: 22067259
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
Acta Pharm Sin B. 2018 Sep;8(5):767-771
pubmed: 30245963
Ther Adv Med Oncol. 2020 Jul 15;12:1758835920940946
pubmed: 32728395
Gynecol Oncol. 2015 Sep;138(3):656-62
pubmed: 26115975
Mol Cancer. 2013 Aug 02;12:86
pubmed: 23915189
Oncotarget. 2015 Nov 10;6(35):37511-25
pubmed: 26462020
Tumour Biol. 2016 Mar;37(3):3017-24
pubmed: 26419593

Auteurs

Mahmood S Mozaffari (MS)

Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, Georgia.

Rafik Abdelsayed (R)

Department of Oral Biology and Diagnostic Sciences, The Dental College of Georgia, Augusta University, Augusta, Georgia.

Classifications MeSH